Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Natalia Gurtowska Jan Adamowicz Tomasz Drewa Tomasz Kloskowski Alina Grzanka |
| Publication date | October 4, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |